GnRH agonist for endometriosis cysts
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests a drug called GnRH agonist to see if it helps people with endometriosis cysts. It might offer a new treatment option for those with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 40 years old.
- You have been diagnosed with endometriosis cysts.
- You are willing to participate and sign a consent form.
- Your periods come regularly every 25 to 35 days for the last 3 months.
- You have not used hormonal birth control, GnRH agonists, or progesterone in the last 3 months.
- You are not pregnant, breastfeeding, or have a history of osteoporosis, blood clotting issues, or heart or blood vessel problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medicine for endometriosis and compares it with an approved drug. It aims to see if the new medicine works as well and is safe. Women with endometriosis who are not planning to get pregnant may join.
This study tests a new medicine called HHK001 for endometriosis. It is compared with a standard treatment (Enantone) to see if it is safe and works well to reduce symptoms.
This trial studies whether giving a GnRH “downshifting” shot before transferring a frozen embryo can improve pregnancy outcomes for people with endometriosis or adenomyosis. It may help by changing hormone activity before the transfer.
This study tests whether a drug called relugolix CT can reduce pelvic pain from endometriosis. You'll have brain scans and pain tests to measure how your body processes pain. It might help if other treatments haven't worked well.
This trial tests whether taking a medication (Rel-CT) after surgery helps improve outcomes for people with endometriosis. It may reduce the chance of symptoms returning after the tissue is removed.
This trial compares an implant that releases the hormone gestrinone with a daily pill called dienogest to see which works better for treating endometriosis symptoms. It might be a good option if you have mild to moderate endometriosis and are looking for a non-surgical treatment.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.